-
PDHA1 Succinylation and Immune Escape in Cholangiocarcinoma
2026-09-18
This 2025 Nature Communications study identifies PDHA1 lysine 83 succinylation as a metabolic-immune control point in cholangiocarcinoma. The modification increases PDHA1 activity, promotes tumor-microenvironmental α-ketoglutarate accumulation, suppresses macrophage MHC-II antigen presentation through OXGR1-MAPK signaling, and may contribute to resistance to gemcitabine–cisplatin chemotherapy.
-
ZIF8 Nanotheranostics for Triple-Negative Breast Cancer
2026-09-18
Li et al. developed FA-PEG@ZIF8@CIP, an ultrasound-responsive nanotheranostic platform that combines folic acid-mediated targeting, pH-responsive Ciprofloxacin release, sonodynamic therapy, chemotherapy, and immune activation. In TNBC models, ultrasound-enhanced treatment increased reactive oxygen species, promoted immunogenic cell death, improved cytotoxic T-cell infiltration, and supported ultrasound imaging-guided therapy.
-
FTH-Linked Ferroptosis in TP53-Mutant Glioblastoma
2026-09-17
The reference study identifies an iron-homeostasis mechanism in which gain-of-function TP53 mutations increase ITCH expression, promote FTH degradation, and expand the free-iron pool in glioblastoma models. This state creates a context-dependent vulnerability to Erastin, particularly when combined with ferric ammonium citrate, while also revealing why TP53-mutant cells can tolerate iron stress before undergoing ferroptosis.
-
Bacitracin (B1670): Practical Research Guide
2026-09-17
Bacitracin (B1670) is a peptide antibiotic for controlled antibacterial research involving bacterial cell wall and peptidoglycan synthesis disruption. This guide covers stock preparation, solvent controls, QC, and interpretation boundaries; the material is for scientific research only and not for diagnostic, therapeutic, or medical use.
-
Lipid Nanoparticles and Tissue-Specific T Cells
2026-09-16
The reference study shows that lipid nanoparticle composition can control systemic trafficking after intramuscular injection and thereby shape organ-specific antigen expression and CD8+ tissue-resident memory T-cell responses. Its findings connect formulation chemistry with localized immunity, providing a framework for designing mRNA vaccines and therapeutic studies around tissue-level protection rather than systemic responses alone.
-
Mycophenolic Acid: Dehydrogenase Inhibitor Guide
2026-09-15
Mycophenolic acid is a dehydrogenase inhibitor that suppresses inosine monophosphate dehydrogenase and constrains guanine-nucleotide biosynthesis. This research-focused guide connects its biochemical rationale with standardized whole-blood immune assays, handling requirements, and experimental limitations.
-
Saracatinib: From Src Signaling to Translation
2026-09-15
Saracatinib (AZD0530) offers translational researchers a way to interrogate Src family kinase and Abl signaling across cancer models while opening a carefully bounded bridge to synaptic biology. This article connects pathway mechanism, assay design, xenograft interpretation, and the Reelin–Apoer2–SFK findings reported in a key ketamine study.
-
Hoechst 33258 for KRas TNT Imaging
2026-09-14
Use Hoechst 33258 as a live-compatible nuclear readout when studying KRas-driven heterogeneity, tunneling nanotubes, and cell mechanics. This workflow combines DNA staining, confocal imaging, cell-cycle profiling, and quantitative nuclear segmentation without treating the stain itself as a direct KRas or TNT marker.
-
Hyperforin–Dlat–Trpv3 Adipose Thermogenesis
2026-09-14
The reference study identifies a non-canonical Dlat–Trpv3–Ca2+–CaMKKβ–AMPK pathway through which hyperforin promotes adipose thermogenesis and counters diet-associated obesity. Its combination of genetic, metabolic, cellular, pharmacokinetic, and imaging evidence positions Dlat-dependent calcium signaling as a useful alternative framework to β3-adrenergic receptor agonism.
-
Cefepime in Resistance and CNS Infection Models
2026-09-13
Cefepime (BMY-28142) is a practical probe for linking antimicrobial phenotype, carbapenemase-gene mobility, and exposure-related neurotoxicity in research models. This guide translates a recent Enterobacter cloacae surveillance study into reproducible assay workflows while keeping CNS applications, resistance interpretation, and safety boundaries distinct.
-
KR-12–Cu(II) Binding: Theory Meets Experiment
2026-09-12
The reference study combines GFN2-xTB/ALPB calculations with potentiometric titration and isothermal titration calorimetry to clarify how the antimicrobial KR-12 peptide coordinates Cu(II). Its main contribution is a chemically resolved interpretation showing that backbone oxygen atoms dominate favorable binding modes, while aspartate and Arg29 strongly influence the interaction.
-
Fumagillin: MetAP-2 Insight for Translation
2026-09-12
Fumagillin is more than an antiangiogenic compound: it is a mechanistically distinctive methionine aminopeptidase-2 inhibitor that connects endothelial biology, tumor models, and exploratory antiparasitic research. This article examines the evidence, assay design, translational boundaries, and strategic opportunities for using Fumagillin in rigorous angiogenesis and cancer research.
-
Firefly Luciferase mRNA Guide
2026-09-11
A scenario-based guide to using Firefly Luciferase mRNA (ARCA, 5-moUTP), SKU R1012, for gene expression, cell viability, and cytotoxicity workflows. It connects transcript design, handling, assay controls, data interpretation, and vendor selection to practical laboratory decisions.
-
nor-Binaltorphimine dihydrochloride Assay Guide
2026-09-11
Use nor-Binaltorphimine dihydrochloride to separate κ-opioid receptor activity from μ-opioid receptor-driven effects in cellular, tissue, and circuit-level experiments. This practical guide converts recent brain-to-spinal pain research into controlled antagonist assays, formulation checks, and troubleshooting decisions.
-
Ciprofloxacin for AMR Transmission Workflows
2026-09-10
Ciprofloxacin connects fluoroquinolone target biology with susceptibility testing, plasmid-transmission analysis, and resistance-aware bacterial infection models. This workflow shows how to use the compound as a phenotypic comparator without confusing antibacterial activity with proof of carbapenemase-gene transfer.